Medical Aspects of Chemical Warfare (2008) - The Black Vault
Medical Aspects of Chemical Warfare (2008) - The Black Vault Medical Aspects of Chemical Warfare (2008) - The Black Vault
Riot Control Agentsability and that CR produced minimal organ-specifictoxicity at many times the human ICt 50, which has beenreported as both 0.7 mg/m 3 within 1 minute 170 and 0.15mg/m 3 within 1 minute. 183,186Upshall 168 studied the reproductive and developmentaleffects of CR on rabbits and rats. The animalswere exposed to inhalation of aerosolized CR at concentrationsof 2, 20, and 200 mg/m 3 for 5 and 7 minutes.Groups of animals were also dosed intragastricallyon days 6, 8, 10, 12, 14, 16, and 18 of pregnancy. Nodose-related effects of CN were observed in any ofthe parameters measured or in the number and typesof malformations observed. No externally visiblemalformations were seen in any group, and no doserelatedeffects of CR were noted in any of the fetusesin any group. Based on the overall observations, theauthor concluded that CR was neither teratogenic norembryotoxic to rabbits or rats.Only one study has reported on the genotoxicity ofCR. Colgrave et al 176 studied the mutagenic potential oftechnical grade CR and its precursor (2-aminodiphenylether) in the various strains of Salmonella typhimurium,as well as in mammalian assay systems. CR and itsprecursor were negative in all the assays, suggestingthat CR is not mutagenic. Further testing is requiredto exclude the genetic threat to humans, as well as todetermine the carcinogenic potential and its abilityto cause other chronic health effects. Husain et al 133studied the effects in rats of CR and CN aerosols onplasma glutamic oxaloacetic transaminase, plasmaglutamic pyruvic transaminase, acid phosphatase, andalkaline phosphatase. The rats exposed to CR exhibitedno change in any of these parameters, whereassignificant increases in all of these parameters occurredin rats exposed to CN, suggesting that CN can causetissue damage.MEDICAL CAREThe effects from RCAs are typically self-limiting,and discomfort is reduced within 30 minutes uponexiting a contaminated area. Usually no medical treatmentis necessary, particularly if the agent is usedin an open area and the dose is minimized. Medicalcomplications are always possible, however, so emergencyservices should be prepared to treat a limitednumber of casualties when RCAs are used for civildisturbance, civilian peacekeeping operations, andtraining. Injury may range from skin and eye irritationto, in rare cases, injuries sustained from explodingdispensing munitions, delayed transient pulmonarysyndromes, or delayed pulmonary edema requiringhospital admission. 4Personal ProtectionShort-term protection can be provided by dry clothingthat covers the arms and legs, because sweat allowsdry agents to adhere to the skin. The standard protectivemask will adequately protect against the inhalationof RCA particles and vapors. When working with bulkquantities of these agents, or in mask confidence chamberswith CS1, CS2, or CR, protective clothing, mask,and gloves that cover all exposed skin areas should beworn. 10 Medical providers do not require protectiononce an exposed patient has been decontaminated.DecontaminationDecontamination is important to reduce injury andcontinued exposure from agent on the skin, hair, andclothing. This is particularly important for those incontact with RCAs in enclosed areas for long periodsof time, such as individuals running mask confidencetraining who are in the chamber repeatedly throughouta single day. CS chamber operators have developederythema, minor skin burns, and blistering on theneck, arms, and other areas that were not continuouslyprotected by a mask or clothing (Figure 13-12).These problems can be avoided if operators wearadequate dermal protection during exposure andshower immediately with soap and water at the endof the training day.When dry agents (CS, CR, CN, and DM) are dispensedin the open air in limited quantities, all that isneeded to remove the agent, particularly when protectiveclothing is worn, is brisk movement: flapping thearms and rubbing the hair in a breeze or standing infront of a large fan. This will disperse most of the particlesfrom the clothing and hair. The mask should beworn during this process to insure that particles blownfrom other people performing the same procedure upwindare not inhaled. However, agent particles adhereto sweaty skin, so completely effective decontaminationrequires clothing removal followed by thoroughwashing of exposed skin and hair.To decontaminate an exposed patient, the contaminatedclothing should be removed before admittanceto a medical treatment facility. The clothing must bestored in a sealed polythene bag and, if laundered,cold water should be used to reduce vaporization ofthe agent. 81 Soap and water are an effective decontaminantfor RCAs; they will not neutralize the agentbut will wash it away. Water should be used in copiousamounts. Soap helps loosen the dry particles and469
Medical Aspects of Chemical WarfareabFig. 13-12. Mask confidence chamber operator after several hours of exposure to concentrated CS. Erythema and blisters arepresent in areas where the skin was exposed. This service member stated that this is the first time he neglected to showerafter training.Photograph: Courtesy of CG Hurst, US Army Medical Research Institute of Chemical Defense.remove them adequately from the skin surface. CR,CN and DM hydrolyze very slowly in water, evenwhen alkali is present. 24 Because these agents do notdecompose in water, washing with soap and water willonly remove them from surfaces. Run-off may produceirritation if it gets into the eyes, so the eyes should beclosed and head lowered during decontamination (ifthe agent is not already in the eyes). Environmentalcontamination from these agents may be persistentand difficult to remove. CS is insoluble in water butwill hydrolyze in water at a pH of 7, with a half-life ofapproximately 15 minutes at room temperature, andextremely rapidly in alkaline solution with a pH of 9,with a half-life of about 1 minute. 71Decontamination solutions used on human skinshould not be caustic to the skin. A solution containing6% sodium bicarbonate, 3% sodium carbonate, and 1%benzalkonium chloride was found to bring promptrelief of symptoms and to hydrolyze CS. 187 No formof hypochlorite should ever be used to decontaminateCS or other RCAs because it can react with CS to producemore toxic chemical byproducts and will furtherirritate tissues. 51 Applying water or soap and water toskin exposed to CS or OC but decontaminated mayresult in a transient worsening of the burning sensation,which should dissipate with continued waterflushing. 3,10 PS liquid can also be decontaminated withsoap and water, and clothing, which can trap vapor,should be removed. 188Water in limited quantities increases the painsymptoms from OC, which has a water solubility of0.090 g/L at 37° C. 24,189 Without decontamination, OCsymptoms should dissipate over time as the body’ssubstance P is diminished. OC resin can also be decontaminatedwith copious amounts of water, liquid soapand water, baby shampoo, alcohol, or cold milk. 22 OCin the eyes can be decontaminated with copious waterflushing, but symptoms may not dissipate for 10 minutes.A compress of cold milk, ice water, or snow canhelp reduce the burning sensation once the individualhas been decontaminated. 22 Substances with high fatcontent, such as whipped cream or ice cream, also aidin decontamination and help reduce pain. 22 AlthoughOC is soluble in vegetable oil and other hydrocarbons,and such solutions can more easily be washed off theskin, hydrocarbons must not be used with solutionsof OC and other RCAs such as CN. 24,190 Commerciallyavailable products, such as Sudecon DecontaminationWipes (Fox Labs International, Clinton Township,Mich); Bio Shield towelettes (Bio Shield, Inc, Raleigh,470
- Page 441 and 442: Medical Aspects of Chemical Warfare
- Page 443 and 444: Medical Aspects of Chemical Warfare
- Page 445 and 446: Medical Aspects of Chemical Warfare
- Page 447 and 448: Medical Aspects of Chemical Warfare
- Page 449 and 450: Medical Aspects of Chemical Warfare
- Page 451 and 452: Medical Aspects of Chemical Warfare
- Page 453 and 454: Medical Aspects of Chemical Warfare
- Page 455 and 456: Medical Aspects of Chemical Warfare
- Page 457 and 458: Medical Aspects of Chemical Warfare
- Page 459 and 460: Medical Aspects of Chemical Warfare
- Page 461 and 462: Medical Aspects of Chemical Warfare
- Page 463 and 464: Medical Aspects of Chemical Warfare
- Page 465 and 466: Medical Aspects of Chemical Warfare
- Page 467 and 468: Medical Aspects of Chemical Warfare
- Page 469 and 470: Medical Aspects of Chemical Warfare
- Page 471 and 472: Medical Aspects of Chemical Warfare
- Page 473 and 474: Medical Aspects of Chemical Warfare
- Page 475 and 476: Medical Aspects of Chemical Warfare
- Page 477 and 478: Medical Aspects of Chemical Warfare
- Page 479 and 480: Medical Aspects of Chemical Warfare
- Page 481 and 482: Medical Aspects of Chemical Warfare
- Page 483 and 484: Medical Aspects of Chemical Warfare
- Page 485 and 486: Medical Aspects of Chemical Warfare
- Page 487 and 488: Medical Aspects of Chemical Warfare
- Page 489 and 490: Medical Aspects of Chemical Warfare
- Page 491: Medical Aspects of Chemical Warfare
- Page 495 and 496: Medical Aspects of Chemical Warfare
- Page 497 and 498: Medical Aspects of Chemical Warfare
- Page 499 and 500: Medical Aspects of Chemical Warfare
- Page 501 and 502: Medical Aspects of Chemical Warfare
- Page 503 and 504: Medical Aspects of Chemical Warfare
- Page 505 and 506: Medical Aspects of Chemical Warfare
- Page 507 and 508: Medical Aspects of Chemical Warfare
- Page 509 and 510: Medical Aspects of Chemical Warfare
- Page 511 and 512: Medical Aspects of Chemical Warfare
- Page 513 and 514: Medical Aspects of Chemical Warfare
- Page 515 and 516: Medical Aspects of Chemical Warfare
- Page 517 and 518: Medical Aspects of Chemical Warfare
- Page 519 and 520: Medical Aspects of Chemical Warfare
- Page 521 and 522: Medical Aspects of Chemical Warfare
- Page 523 and 524: Medical Aspects of Chemical Warfare
- Page 525 and 526: Medical Aspects of Chemical Warfare
- Page 527 and 528: Medical Aspects of Chemical Warfare
- Page 529 and 530: Medical Aspects of Chemical Warfare
- Page 531 and 532: Medical Aspects of Chemical Warfare
- Page 534 and 535: Triage of Chemical CasualtiesChapte
- Page 536 and 537: Triage of Chemical Casualtiesreceiv
- Page 538 and 539: Triage of Chemical Casualtiesentran
- Page 540 and 541: Triage of Chemical Casualtiescatego
Riot Control Agentsability and that CR produced minimal organ-specifictoxicity at many times the human ICt 50, which has beenreported as both 0.7 mg/m 3 within 1 minute 170 and 0.15mg/m 3 within 1 minute. 183,186Upshall 168 studied the reproductive and developmentaleffects <strong>of</strong> CR on rabbits and rats. <strong>The</strong> animalswere exposed to inhalation <strong>of</strong> aerosolized CR at concentrations<strong>of</strong> 2, 20, and 200 mg/m 3 for 5 and 7 minutes.Groups <strong>of</strong> animals were also dosed intragastricallyon days 6, 8, 10, 12, 14, 16, and 18 <strong>of</strong> pregnancy. Nodose-related effects <strong>of</strong> CN were observed in any <strong>of</strong>the parameters measured or in the number and types<strong>of</strong> malformations observed. No externally visiblemalformations were seen in any group, and no doserelatedeffects <strong>of</strong> CR were noted in any <strong>of</strong> the fetusesin any group. Based on the overall observations, theauthor concluded that CR was neither teratogenic norembryotoxic to rabbits or rats.Only one study has reported on the genotoxicity <strong>of</strong>CR. Colgrave et al 176 studied the mutagenic potential <strong>of</strong>technical grade CR and its precursor (2-aminodiphenylether) in the various strains <strong>of</strong> Salmonella typhimurium,as well as in mammalian assay systems. CR and itsprecursor were negative in all the assays, suggestingthat CR is not mutagenic. Further testing is requiredto exclude the genetic threat to humans, as well as todetermine the carcinogenic potential and its abilityto cause other chronic health effects. Husain et al 133studied the effects in rats <strong>of</strong> CR and CN aerosols onplasma glutamic oxaloacetic transaminase, plasmaglutamic pyruvic transaminase, acid phosphatase, andalkaline phosphatase. <strong>The</strong> rats exposed to CR exhibitedno change in any <strong>of</strong> these parameters, whereassignificant increases in all <strong>of</strong> these parameters occurredin rats exposed to CN, suggesting that CN can causetissue damage.MEDICAL CARE<strong>The</strong> effects from RCAs are typically self-limiting,and discomfort is reduced within 30 minutes uponexiting a contaminated area. Usually no medical treatmentis necessary, particularly if the agent is usedin an open area and the dose is minimized. <strong>Medical</strong>complications are always possible, however, so emergencyservices should be prepared to treat a limitednumber <strong>of</strong> casualties when RCAs are used for civildisturbance, civilian peacekeeping operations, andtraining. Injury may range from skin and eye irritationto, in rare cases, injuries sustained from explodingdispensing munitions, delayed transient pulmonarysyndromes, or delayed pulmonary edema requiringhospital admission. 4Personal ProtectionShort-term protection can be provided by dry clothingthat covers the arms and legs, because sweat allowsdry agents to adhere to the skin. <strong>The</strong> standard protectivemask will adequately protect against the inhalation<strong>of</strong> RCA particles and vapors. When working with bulkquantities <strong>of</strong> these agents, or in mask confidence chamberswith CS1, CS2, or CR, protective clothing, mask,and gloves that cover all exposed skin areas should beworn. 10 <strong>Medical</strong> providers do not require protectiononce an exposed patient has been decontaminated.DecontaminationDecontamination is important to reduce injury andcontinued exposure from agent on the skin, hair, andclothing. This is particularly important for those incontact with RCAs in enclosed areas for long periods<strong>of</strong> time, such as individuals running mask confidencetraining who are in the chamber repeatedly throughouta single day. CS chamber operators have developederythema, minor skin burns, and blistering on theneck, arms, and other areas that were not continuouslyprotected by a mask or clothing (Figure 13-12).<strong>The</strong>se problems can be avoided if operators wearadequate dermal protection during exposure andshower immediately with soap and water at the end<strong>of</strong> the training day.When dry agents (CS, CR, CN, and DM) are dispensedin the open air in limited quantities, all that isneeded to remove the agent, particularly when protectiveclothing is worn, is brisk movement: flapping thearms and rubbing the hair in a breeze or standing infront <strong>of</strong> a large fan. This will disperse most <strong>of</strong> the particlesfrom the clothing and hair. <strong>The</strong> mask should beworn during this process to insure that particles blownfrom other people performing the same procedure upwindare not inhaled. However, agent particles adhereto sweaty skin, so completely effective decontaminationrequires clothing removal followed by thoroughwashing <strong>of</strong> exposed skin and hair.To decontaminate an exposed patient, the contaminatedclothing should be removed before admittanceto a medical treatment facility. <strong>The</strong> clothing must bestored in a sealed polythene bag and, if laundered,cold water should be used to reduce vaporization <strong>of</strong>the agent. 81 Soap and water are an effective decontaminantfor RCAs; they will not neutralize the agentbut will wash it away. Water should be used in copiousamounts. Soap helps loosen the dry particles and469